Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASE: Buprenorphine vs Oxycodone in Trauma Care
NCT07435077Phase 4Not yet recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Mar 2027
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine extended-release injection in acute pain, sponsored by Wake Forest University Health Sciences. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
buprenorphine extended-release injection
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT07435077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07435077.